newsfilter
← Latest News
GlobeNewswire·

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

ATLANTA, GA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today